Literature DB >> 28251316

Editor's comment on "CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein".

Stefan Hohmann1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28251316     DOI： 10.1007/s00438-017-1300-x

Source DB:  PubMed          Journal:  Mol Genet Genomics        ISSN： 1617-4623            Impact factor:   3.291


× No keyword cloud information.
  3 in total

1.  Introducing precise genetic modifications into human 3PN embryos by CRISPR/Cas-mediated genome editing.

Authors:  Xiangjin Kang; Wenyin He; Yuling Huang; Qian Yu; Yaoyong Chen; Xingcheng Gao; Xiaofang Sun; Yong Fan
Journal:  J Assist Reprod Genet       Date:  2016-04-06       Impact factor: 3.412

2.  CRISPR, the disruptor.

Authors:  Heidi Ledford
Journal:  Nature       Date:  2015-06-04       Impact factor: 49.962

3.  CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes.

Authors:  Puping Liang; Yanwen Xu; Xiya Zhang; Chenhui Ding; Rui Huang; Zhen Zhang; Jie Lv; Xiaowei Xie; Yuxi Chen; Yujing Li; Ying Sun; Yaofu Bai; Zhou Songyang; Wenbin Ma; Canquan Zhou; Junjiu Huang
Journal:  Protein Cell       Date:  2015-04-18       Impact factor: 14.870
  3 in total
  1 in total

1.  Correction of β-thalassemia mutant by base editor in human embryos.

Authors:  Puping Liang; Chenhui Ding; Hongwei Sun; Xiaowei Xie; Yanwen Xu; Xiya Zhang; Ying Sun; Yuanyan Xiong; Wenbin Ma; Yongxiang Liu; Yali Wang; Jianpei Fang; Dan Liu; Zhou Songyang; Canquan Zhou; Junjiu Huang
Journal:  Protein Cell       Date:  2017-09-23       Impact factor: 14.870
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.